Pharmaceutical Information |
Drug Name |
Eletriptan |
Drug ID |
BADD_D00755 |
Description |
Eletriptan is a second generation triptan drug developed by Pfizer Inc for the treatment of migraine headaches. |
Indications and Usage |
For the acute treatment of migraine with or without aura in adults. |
Marketing Status |
Prescription |
ATC Code |
N02CC06 |
DrugBank ID |
DB00216
|
KEGG ID |
D07887
|
MeSH ID |
C115647
|
PubChem ID |
77993
|
TTD Drug ID |
D02DMQ
|
NDC Product Code |
Not Available |
Synonyms |
eletriptan | (R)-3-((1-methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole | UK 166,044 | UK-166044 | UK 166044 | UK-166,044 | Relpax | UK-116044-04 | UK-116,044-04 | eletriptan hydrobromide | (R)-3-((1-methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole monohydrobromide | 3-(1-methyl-2-pyrrolidinylmethyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole hydrobromide |
|
Chemical Information |
Molecular Formula |
C22H26N2O2S |
CAS Registry Number |
143322-58-1 |
SMILES |
CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4 |
Chemical Structure |
|
|
ADR Related Proteins Induced by Drug |
ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
Not Available | Not Available | Not Available | Not Available | Not Available |
|
ADRs Induced by Drug |
|